Healthcare -
Biotechnology - NASDAQ - US
$ 0.9537
0.921 %
$ 41.6 M
Market Cap
-0.62
P/E
TPST - STOCK-BASED COMPENSATION
Stock-based Compensation TPST - Tempest Therapeutics, Inc.
2.55 M
LAST VALUE
51.79%
2 YEAR CAGR
12.28%
5 YEAR CAGR
-6.70%
10 YEAR CAGR